Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
10/2008
10/09/2008US20080249152 Complexes with radionuclides; radiotherapy or diagnosis of tumors; e.g. two tetraazacyclododecanetetraacetic acid (DOTA) chelators conjugated to the side of biotin
10/09/2008US20080249146 Bicyclic antivirals for hepatitis C treatment; e.g. 1-cyclohexyl-2-phenyl-1H-thieno[3,2-d]imidazole-5-carboxylic acid
10/09/2008US20080249114 Beta-3 adrenergic receptor agonists; urinary tract infections, incontinence, gastrointestinal disorders, dysmenorrhea, obesity; tocolytic, anxiolytic, antidiabetic agents; antidepressants; 4-(2-hydroxy-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
10/09/2008CA2682377A1 Heteroaryl derivatives
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1485390B1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
10/08/2008EP1478628B1 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282930A Fab I inhibitor and process for preparing same
10/07/2008US7432372 Fluorinated resorufin compounds and their application
10/07/2008US7432271 Atherosclerosis; anticholesterol agents; cardiovascular disorders; stroke; thrombosis; hypotensive agents; restenosis; antidiabetic agents; antiarthritic agents; anticancer agnets; inflammatory bowel disorders
10/07/2008US7432267 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile
10/02/2008WO2008118718A2 2-aminopyridine analogs as glucokinase activators
10/02/2008WO2008118030A1 Process for preparation of pure polymorphic form 1 of clopidogrel hydrogensulfate
10/02/2008WO2008117269A2 Heterotri cyciii c compounds as serotonergic and/or dopaminergic agents and uses thereof
10/02/2008WO2008116881A1 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
10/02/2008WO2008079873A3 Thiazolyl compounds useful as kinase inhibitors
10/02/2008US20080242698 Antiepilrptic agents; antiischemic agents; vision defects; skin disorders; muscular disorders; anticonvulsants;analgesics; Parkinson's disease; huntington's disease; amyotrophic lateral sclerosis; multiple sclerosis
10/02/2008US20080242665 1-(4-((2-(2-aminopyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfonyl)ethanone; lipid kinase inhibitor; anticarcinogenic agent;
10/02/2008US20080241959 Bioconjugation; drug screening
10/02/2008CA2682012A1 Substituted pyrrolidinamides, manufacturing and use thereof as medicaments
10/02/2008CA2681695A1 2-aminopyridine analogs as glucokinase activators
10/01/2008EP1975165A1 Substituted pyrrolidinamides, their production and utilisation as medicine
10/01/2008EP1973911A2 Azaindoles useful as inhibitors of janus kinases
10/01/2008EP1420780B1 Cyclopropyl and cyclobutyl epothilone analogs
10/01/2008CN101277949A Dipeptidyl peptidase-iv inhibitors
10/01/2008CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
09/2008
09/30/2008US7429660 Induce immunology response; anticancer agents
09/30/2008US7429609 Pyrazole compound and medicinal composition containing the same
09/30/2008US7429597 Heterobicyclic compound such as quinazoline anticoagulants and factor X inhibitors
09/30/2008US7429587 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
09/30/2008US7429579 antagonism/inhibition, of the D3 receptor; substance abuse.
09/25/2008WO2008115990A1 Methods of preparation and resolution of e/z isomers of vinylfuro[2,3-d] pyrimidine and their biological activities and related compositions and methods of treatment
09/25/2008WO2008113456A1 Tetrahydroquinoline derivatives and use of same for treating cancer
09/25/2008WO2008113255A1 Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof
09/25/2008WO2008097428A3 Compounds and compositions as modulators of gpr119 activity
09/25/2008WO2008060597A3 Compounds useful as protein kinase inhibitors
09/25/2008US20080234482 Prevent proliferation of hepatitis C virus; low toxicity
09/25/2008US20080234287 Lung cancer, gastric cancer, liver cancer, leucocythemia, endometrioma, oophoroma, mammary cancer, colon cancer, prostatic cancer, or pituitary gland cancer; N (N',N'-dimethylaminoethyl)benzo[b]thieno[2,1-c]naphthalimide
09/25/2008US20080234250 Heterocyclic Condensed Compounds Useful as Antidiuretic Agents
09/25/2008DE102007013854A1 Tetrahydrochinoline Tetrahydroquinolines
09/25/2008DE102005060690B4 Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen Salts of clopidogrel with polyanions and their use for the preparation of pharmaceutical formulations
09/25/2008CA2681261A1 Tetrahydroquinoline derivatives and the use thereof for the treatment of cancer
09/24/2008EP1971611A1 Anti-viral compounds
09/24/2008EP1971610A1 Salts of clopidogrel with polynions and their use for manufacturing pharmaceutical formulations
09/24/2008EP1971609A1 Thienopyridine derivatives as modulators of metabotropic glutamate receptors
09/24/2008EP1971601A2 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
09/24/2008EP1971597A2 N-(5-membered heteroaromatic ring)-amido anti-viral compounds
09/24/2008EP1971596A2 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands
09/24/2008EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/24/2008EP1387827B1 Synthesis of cyclopentadiene derivatives
09/24/2008CN101273047A Thieno[2,3-B]pyridine-5-carbonitriles as protein kinase inhibitors
09/24/2008CN101272806A 过早排卵抑制剂 Premature ovulation inhibitors
09/24/2008CN101270087A Isoquinoline derivatives and methods of use thereof
09/23/2008US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease
09/23/2008US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
09/23/2008US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma
09/23/2008US7427445 Compound capable of being used in organic layer of organic light emitting device
09/23/2008CA2432872C Pyrazole compounds useful as protein kinase inhibitors
09/18/2008US20080227989 Prepared by reacting oxidized methyl triallyl acetate with a sulfuring agent and a Lewis acid of boron trifluoride and ethyl ether complex or boron trichloride and ethyl ether complex; anchor for growing alpha -helical peptides
09/18/2008US20080227961 Chelation compounds, radionuclides
09/18/2008US20080226579 Using water soluble ion exchange resin; stability; masking bitter taste
09/18/2008US20080224099 Carboxylic acid-modified edot for bioconjugation
09/17/2008EP1970373A1 Alicyclic heterocyclic compound
09/17/2008EP1968983A1 Method for preparing a mixed solvate of olanzapine
09/17/2008EP1968982A2 Thieno (3,2-c) pyridine compounds
09/17/2008EP1968979A2 9-membered heterobicyclic compounds as inhibitors of protein kinases
09/17/2008EP1968580A2 2-(ih-thieno [3,2-c] pyrazol-3yl)-ih-indole derivatives and related compounds as tec kinase inhibitors for the treatment of inflammations and immunological disorders
09/17/2008CN101268083A Synthesis of cyclopentadienedithiophene derivatives
09/17/2008CN101268082A Thienopyrimidine and thienopyridine derivatives as FLT-3 kinase inhibitors
09/17/2008CN101268081A 5,6-dimethylthieno(2,3-DI) pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus
09/17/2008CN100418971C Heteroryl-fused pyrimidinyl compounds as anticancer agents
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425627 Methods of synthesizing olanzapine
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/16/2008CA2102301C Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
09/12/2008WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008108742A2 Polymorphic forms of clopidogrel hydrobromide
09/12/2008WO2008108442A1 Novel porphyrazine derivative and intermediate thereof, method for production of novel porphyrazine derivative and intermediate thereof, and use of porphyrazine derivative
09/12/2008WO2008108309A1 Fused pyridine derivative
09/12/2008WO2008108291A1 Process for production of prasugrel hydrochloride having high purity
09/12/2008WO2008107436A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
09/12/2008WO2008089453A3 Inhibitors of d-amino acid oxidase
09/12/2008CA2680177A1 Metalloprotease inhibitors containing a heterocyclic moiety
09/12/2008CA2678492A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
09/11/2008US20080221131 Respiratory system disorders; asthma; chronic obstructive pulminary disease; antiproliferative agents; immunosuppressants
09/11/2008US20080221094 Metalloprotease inhibitors containing a squaramide moiety
09/11/2008US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation
09/10/2008EP1966220A2 Mglur1 anatgonists as therapeutic agents
09/10/2008EP1966219A1 Process for the preparation of s-(+)-clopidogrel by optical resolution
09/10/2008EP1966207A2 Pyrimidine derivatives for the treatment of abnormal cell growth
09/10/2008EP1966137A2 Piperidine derivatives
09/10/2008EP1966134A1 Novel fused pyrrole derivatives
09/10/2008EP1349861B1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS
09/10/2008CN101263145A 4-amino-thieno[3,2-C] pyridine-7-carboxylic acid derivatives
09/10/2008CN101260113A 6H-thiochromeno[4,3-d][1,2,4]triazole[4,3-a]pyrimidines compounds with plant pathogen epiphyte resisting activity
09/10/2008CN101260112A Acethydrazide derivatives containing thieno[3.2-c]pyridine, preparation method and use thereof
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 214